![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Factors driving decisions in the use of HIV Pre-Exposure
Prophylaxis: Data from a real-world study in the United States
|
|
|
ID Week 2023 Oct 13
Yohance Whiteside, PhD1; Abigail McMillan, MSc2; Fritha Hennessy, PhD2; Phoebe Salmon, BSc2; Tim Holbrook, BSc2; Bekana K. Tadese, PhD1
1Merck & Co., Inc., Rahway, NJ, USA; 2Adelphi Real World, Bollington, United Kingdom
![1016231](../images/101523/101523-29/1016231.gif)
![1016232](../images/101523/101523-29/1016232.gif)
![1016233](../images/101523/101523-29/1016233.gif)
![1016234](../images/101523/101523-29/1016234.gif)
![1016235](../images/101523/101523-29/1016235.gif)
![1016236](../images/101523/101523-29/1016236.gif)
![1016237](../images/101523/101523-29/1016237.gif)
![1016238](../images/101523/101523-29/1016238.gif)
![1016239](../images/101523/101523-29/1016239.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|